Literature DB >> 22237750

Renal BOLD-MRI does not reflect renal function in chronic kidney disease.

Henrik J Michaely1, Linda Metzger, Stefan Haneder, Jan Hansmann, Stefan O Schoenberg, Ulrike I Attenberger.   

Abstract

Renal blood oxygen level-dependent magnetic resonance imaging (BOLD-MRI) is a noninvasive fast technique to characterize renal function. Here we evaluated the impact of renal function on the relaxation rate (R2(*)) in the cortex and medulla to provide baseline data for further use of renal BOLD-MRI. This parameter was evaluated in 400 patients scheduled for abdominal imaging who underwent transversal blood oxygen level-dependent measurements with a multi-echo gradient-echo sequence with 12 echo times. The loss of phase coherence (T2(*)) maps were generated in which kidney regions of interest were selected to differentiate the medulla and cortex, and R2(*) was equated to 1/T2(*). Individual R2(*) values were, in turn, correlated to the eGFR (MDRD formula of 280 patients with available serum creatinine measurements), age, and gender each for 1.5 and 3.0 T field-strength scans of 342 patients. At both the field strengths, no significant differences in R2(*) of the cortex and medulla were found between patient gender, age, eGFR, or between different stages of chronic kidney disease determined using the KDOQI system. Thus, BOLD-MRI of a non-specific patient population failed to discriminate between the patients with various stages of chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22237750     DOI: 10.1038/ki.2011.455

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  51 in total

1.  [Functional magnetic resonance imaging for evaluation of radiation-induced renal damage].

Authors:  S Haneder; J Boda-Heggemann; S O Schoenberg; H J Michaely
Journal:  Radiologe       Date:  2012-03       Impact factor: 0.635

Review 2.  [Functional magnetic resonance imaging of the kidneys].

Authors:  R S Lanzman; M Notohamiprodjo; H J Wittsack
Journal:  Radiologe       Date:  2015-12       Impact factor: 0.635

Review 3.  Renal relevant radiology: renal functional magnetic resonance imaging.

Authors:  Behzad Ebrahimi; Stephen C Textor; Lilach O Lerman
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-26       Impact factor: 8.237

4.  In vivo sodium (23Na) imaging of the human kidneys at 7 T: preliminary results.

Authors:  Stefan Haneder; Vladimir Juras; Henrik J Michaely; Xeni Deligianni; Oliver Bieri; Stefan O Schoenberg; Siegfried Trattnig; Štefan Zbýň
Journal:  Eur Radiol       Date:  2013-10-02       Impact factor: 5.315

Review 5.  Atherosclerotic renal artery stenosis: current status.

Authors:  Soon Hyo Kwon; Lilach O Lerman
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

Review 6.  MRI-detectable nanoparticles: the potential role in the diagnosis of and therapy for chronic kidney disease.

Authors:  Jennifer R Charlton; Scott C Beeman; Kevin M Bennett
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

7.  Evaluation of renal dysfunction using texture analysis based on DWI, BOLD, and susceptibility-weighted imaging.

Authors:  Jiule Ding; Zhaoyu Xing; Zhenxing Jiang; Hua Zhou; Jia Di; Jie Chen; Jianguo Qiu; Shengnan Yu; Liqiu Zou; Wei Xing
Journal:  Eur Radiol       Date:  2018-12-17       Impact factor: 5.315

Review 8.  Current MRI techniques for the assessment of renal disease.

Authors:  Takamune Takahashi; Feng Wang; Christopher C Quarles
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-05       Impact factor: 2.894

Review 9.  Functional Magnetic Resonance Imaging of the Kidneys-With and Without Gadolinium-Based Contrast.

Authors:  Jeff L Zhang
Journal:  Adv Chronic Kidney Dis       Date:  2017-05       Impact factor: 3.620

10.  Quantitative in vivo 23Na MR imaging of the healthy human kidney: determination of physiological ranges at 3.0T with comparison to DWI and BOLD.

Authors:  Stefan Haneder; Paul Kettnaker; Simon Konstandin; John N Morelli; Lothar R Schad; Stefan O Schoenberg; Henrik J Michaely
Journal:  MAGMA       Date:  2013-03-09       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.